What is Satellos Bioscience Inc?
, a biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia. The company uses its proprietary platform MyoReGenX, an automated microscopy system that recapitulates the muscle stem cell environment ex-vivo. The company is listed on the OTCQB in USA, operating in the Healthcare sector, with a market capitalisation of 187.67M, and a P/E ratio of 4.7x.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.